Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim®, t:slim G4™ and t:flex® Insulin Pumps, today announced that Brian Hansen has joined the Company as Executive Vice President and Chief Commercial Officer, and Lori Gildea as Vice President, Sales.
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System (OmniPod System), today announced it has entered into a definitive agreement to sell its wholly-owned Neighborhood Diabetes supplies business to Liberty Medical, LLC (Liberty Medical), a leading provider of mail order medical supplies, for $5 million in cash.
#product & service
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly adjusted revenues of $2.992 billion for the first fiscal quarter ended December 31, 2015, an increase of 45.9 percent over the prioryear period as reported, or 53.8 percent on a currency-neutral basis.
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, reported financial and operational results for the year ended December 31, 2015 and provided an outlook for the coming quarters. LabStyle's revenues for 2015 amounted to approximately $823,000 compared to approximately $51,000 in 2014. Fourth quarter revenues for 2015 amounted to approximately $308,000 compared to approximately $273,000 in the third quarter of 2015.
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced that David A. Lemoine has been appointed to Insulet's Board of Directors. With his appointment, the Board is now comprised of nine directors, eight of whom are independent.
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim®, t:flex® and t:slim G4™ Insulin Pumps, plans to release its fourth quarter and full year 2015 results after the financial markets close on Wednesday, February 24, 2016.
Brighter's integrated and connected aid for insulin-treated diabetics, Actiste®, has now been formally registered as Brighter's trademark within the EU. In the fall of 2015, Brighter decided that the new brand Actiste will replace the product's former name Brighter One.
#bgm
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following upcoming investor healthcare conferences: 2016 RBC Capital Markets Global Healthcare Conference February 24, 2016, at 2:05 p.m. ET, and Barclays Global 2016 Healthcare Conference, March 15, 2016. at 11:15 a.m. ET.
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim®, t:flex® and t:slim G4™ Insulin Pumps, today announced that Kim Blickenstaff, president and CEO, will present a company update at the Cowen and Company 36th Annual Health Care Conference in Boston, MA. The presentation will take place on Wednesday, March 9, 2016 at 8:00am Eastern Time (5:00am Pacific Time).
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim®, t:flex® and t:slim G4™ Insulin Pumps, today reported its financial results for the quarter and year ended December 31, 2015. As of December 31, 2015, the Company had $73.1 million in cash, cash equivalents and short-term investments. For the fourth quarter of 2015, operating expenses totaled $24.7 million compared to $24.0 million for the same period of 2014. For the year ended December 31, 2015, operating expenses totaled $95.6 million compared to $90.9 million for the same period of 2014.